Phenotypes in children with GNAO1 encephalopathy in China

BackgroundThe GNAO1 gene encodes the α-subunit (Gαo) of the heterotrimeric guanine nucleotide-binding protein (G protein). The aim of this study was to explore the clinical characteristics of patients with GNAO1 pathogenic variations.MethodsTen patients with pathogenic variations in GNAO1 were enrol...

Full description

Bibliographic Details
Main Authors: Yanmei Li, Hong Chen, Lin Li, Xueyan Cao, Xin Ding, Li Chen, Dezhi Cao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1086970/full
_version_ 1797733510039994368
author Yanmei Li
Yanmei Li
Hong Chen
Hong Chen
Lin Li
Xueyan Cao
Xueyan Cao
Xin Ding
Li Chen
Dezhi Cao
Dezhi Cao
author_facet Yanmei Li
Yanmei Li
Hong Chen
Hong Chen
Lin Li
Xueyan Cao
Xueyan Cao
Xin Ding
Li Chen
Dezhi Cao
Dezhi Cao
author_sort Yanmei Li
collection DOAJ
description BackgroundThe GNAO1 gene encodes the α-subunit (Gαo) of the heterotrimeric guanine nucleotide-binding protein (G protein). The aim of this study was to explore the clinical characteristics of patients with GNAO1 pathogenic variations.MethodsTen patients with pathogenic variations in GNAO1 were enrolled from the Shenzhen Children's Hospital. Clinical data from several cases previously reported from China were also included and analyzed.ResultsTwenty-seven patients with variations in GNAO1 were analyzed (10 patients from Shenzhen Children's Hospital, 17 patients from previously published studies) including 12 boys and 15 girls. The median age of onset was 3 months with moderate to severe global developmental delay. Nineteen different GNAO1 heterozygous variants were identified. Epilepsy was observed in 18 patients (67%, 18/27), movement disorder (MD) was observed in 22 patients (81%, 22/27), and both were seen in 13 patients (48%, 13/27). Seizures typically presented as focal seizures in all patients with epilepsy. MD typically presented as dystonia and chorea. Loss-of-function (LOF) or partial loss-of-function (PLOF) mutations were more frequent in patients with developmental and epileptic encephalopathy (p = 0.029). Interictal electroencephalograms showed multifocal or diffuse epileptiform discharges. The most common magnetic resonance imaging finding was widened extracerebral space. In contrast to MD, in which improvements were not common, seizures were easily controlled by anti-seizure medications. Severe dystonia in three patients was effectively treated by deep brain stimulation. Seven (26%, 7/27) patients died of respiratory complications, status dystonicus, choreoathetosis, or sudden unexpected death in epilepsy.ConclusionWe analyzed clinical data of 27 cases of GNAO1-related encephalopathy in China. MD seemed to be the central feature and was most difficult to control. LOF or PLOF variants were significantly associated with developmental and epileptic encephalopathy. The active intervention of severe dystonia may prevent death due to status dystonicus. However, future studies with larger samples are needed to confirm these results.
first_indexed 2024-03-12T12:30:07Z
format Article
id doaj.art-dc4f29918c0c4997b9acf2a8f9d03e1b
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-03-12T12:30:07Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-dc4f29918c0c4997b9acf2a8f9d03e1b2023-08-29T16:23:49ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602023-08-011110.3389/fped.2023.10869701086970Phenotypes in children with GNAO1 encephalopathy in ChinaYanmei Li0Yanmei Li1Hong Chen2Hong Chen3Lin Li4Xueyan Cao5Xueyan Cao6Xin Ding7Li Chen8Dezhi Cao9Dezhi Cao10Shenzhen Children’s Hospital, Shantou University, Shenzhen, ChinaDepartment of Neurology, Shenzhen Children’s Hospital, Shenzhen, ChinaDepartment of Neurology, Shenzhen Children’s Hospital, Shenzhen, ChinaSurgery Division, Epilepsy Center, Shenzhen Children’s Hospital, Shenzhen, ChinaSurgery Division, Epilepsy Center, Shenzhen Children’s Hospital, Shenzhen, ChinaDepartment of Neurology, Shenzhen Children’s Hospital, Shenzhen, ChinaSurgery Division, Epilepsy Center, Shenzhen Children’s Hospital, Shenzhen, ChinaDepartment of Neurology, Shenzhen Children’s Hospital, Shenzhen, ChinaDepartment of Neurology, Shenzhen Children’s Hospital, Shenzhen, ChinaDepartment of Neurology, Shenzhen Children’s Hospital, Shenzhen, ChinaSurgery Division, Epilepsy Center, Shenzhen Children’s Hospital, Shenzhen, ChinaBackgroundThe GNAO1 gene encodes the α-subunit (Gαo) of the heterotrimeric guanine nucleotide-binding protein (G protein). The aim of this study was to explore the clinical characteristics of patients with GNAO1 pathogenic variations.MethodsTen patients with pathogenic variations in GNAO1 were enrolled from the Shenzhen Children's Hospital. Clinical data from several cases previously reported from China were also included and analyzed.ResultsTwenty-seven patients with variations in GNAO1 were analyzed (10 patients from Shenzhen Children's Hospital, 17 patients from previously published studies) including 12 boys and 15 girls. The median age of onset was 3 months with moderate to severe global developmental delay. Nineteen different GNAO1 heterozygous variants were identified. Epilepsy was observed in 18 patients (67%, 18/27), movement disorder (MD) was observed in 22 patients (81%, 22/27), and both were seen in 13 patients (48%, 13/27). Seizures typically presented as focal seizures in all patients with epilepsy. MD typically presented as dystonia and chorea. Loss-of-function (LOF) or partial loss-of-function (PLOF) mutations were more frequent in patients with developmental and epileptic encephalopathy (p = 0.029). Interictal electroencephalograms showed multifocal or diffuse epileptiform discharges. The most common magnetic resonance imaging finding was widened extracerebral space. In contrast to MD, in which improvements were not common, seizures were easily controlled by anti-seizure medications. Severe dystonia in three patients was effectively treated by deep brain stimulation. Seven (26%, 7/27) patients died of respiratory complications, status dystonicus, choreoathetosis, or sudden unexpected death in epilepsy.ConclusionWe analyzed clinical data of 27 cases of GNAO1-related encephalopathy in China. MD seemed to be the central feature and was most difficult to control. LOF or PLOF variants were significantly associated with developmental and epileptic encephalopathy. The active intervention of severe dystonia may prevent death due to status dystonicus. However, future studies with larger samples are needed to confirm these results.https://www.frontiersin.org/articles/10.3389/fped.2023.1086970/fullGNAO1geneepilepsymovement disorderencephalopathystatus dystonicus
spellingShingle Yanmei Li
Yanmei Li
Hong Chen
Hong Chen
Lin Li
Xueyan Cao
Xueyan Cao
Xin Ding
Li Chen
Dezhi Cao
Dezhi Cao
Phenotypes in children with GNAO1 encephalopathy in China
Frontiers in Pediatrics
GNAO1
gene
epilepsy
movement disorder
encephalopathy
status dystonicus
title Phenotypes in children with GNAO1 encephalopathy in China
title_full Phenotypes in children with GNAO1 encephalopathy in China
title_fullStr Phenotypes in children with GNAO1 encephalopathy in China
title_full_unstemmed Phenotypes in children with GNAO1 encephalopathy in China
title_short Phenotypes in children with GNAO1 encephalopathy in China
title_sort phenotypes in children with gnao1 encephalopathy in china
topic GNAO1
gene
epilepsy
movement disorder
encephalopathy
status dystonicus
url https://www.frontiersin.org/articles/10.3389/fped.2023.1086970/full
work_keys_str_mv AT yanmeili phenotypesinchildrenwithgnao1encephalopathyinchina
AT yanmeili phenotypesinchildrenwithgnao1encephalopathyinchina
AT hongchen phenotypesinchildrenwithgnao1encephalopathyinchina
AT hongchen phenotypesinchildrenwithgnao1encephalopathyinchina
AT linli phenotypesinchildrenwithgnao1encephalopathyinchina
AT xueyancao phenotypesinchildrenwithgnao1encephalopathyinchina
AT xueyancao phenotypesinchildrenwithgnao1encephalopathyinchina
AT xinding phenotypesinchildrenwithgnao1encephalopathyinchina
AT lichen phenotypesinchildrenwithgnao1encephalopathyinchina
AT dezhicao phenotypesinchildrenwithgnao1encephalopathyinchina
AT dezhicao phenotypesinchildrenwithgnao1encephalopathyinchina